financing

News

Sofinnova has raised €1.2bn that it says could support 50 to 60 companies across biotech, medtech, industrial biotech, and digital medicine.

News

Eikon has added to its already copious cash reserves with a $351m round for its expanding pipeline of cancer therapies.

News

Abcuro has raised $200m in financing that should allow it to complete a pivotal trial of ulviprubart for rare disease inclusion body myositis (IBM).

News

Metsera and Maze Therapeutics have become the second and third biotechs to complete an IPO on the Nasdaq this year.

News

Recent financings in the digital health and AI space include rounds for Rad AI, Eleos, Allara Health, Manas AI, Delfina Care, and Grey Matter Neuro.

News

Quibim has raised $50 million in first-round financing to support the rollout of its AI biomarkers for use in the analysis of medical imaging.